Mesenchymal stromal cells (MSCs), given their regenerative potential, are being investigated as a potential therapeutic tool for cartilage lesions. MSCs express several bioactive molecules which act in a paracrine fashion to modulate the tissue microenvironment. Yet, little is known about the divergence of these signalling molecules in different MSC populations. The present study investigated secretomes of stromal cells harvested from Hoffa's fat pad (HFPSCs), synovial membrane (SMSCs), umbilical cord (UCSCs) and cartilage (ACs) by quantitative liquid chromatography-mass spectrometry (LC-MS/MS) proteomics. Also, multiplex protein arrays and functional assays were performed to compare the constitutive immunomodulatory capabilities of different MSCs. Proteins involved in extracellular matrix degradation and inflammation, such as matrix metalloproteinases (MMPs), interleukin (IL)-17 and complement factors, were downregulated in UCSCs as compared to adult cell sources. Additionally, secretion of transforming growth factor (TGF)-β1 and prostaglandin E2 (PGE2) was enhanced in UCSC supernatants. UCSCs were superior in inhibiting peripheral blood mononuclear cell (PBMC) proliferation, migration and cytokine secretion as compared to adult stromal cells. SMSCs significantly suppressed the proliferation of PBMCs only if they were primed with pro-inflammatory cytokines. Although all cell types repressed human leukocyte antigen-DR isotype (HLA-DR) surface expression and cytokine release by activated macrophages, only UCSCs significantly blocked IL-6 and IL-12 production. Furthermore, UCSCs supernatants increased aggrecan gene expression in twodimensional chondrocyte cultures. The data demonstrated that UCSCs displayed superior anti-inflammatory and immunosuppressive properties than stromal cells from adult tissues. This allogeneic cell source could potentially be considered as an adjuvant therapy for articular cartilage repair.
Introduction
Articular cartilage lesions associate with pain, discomfort and inflammation of the synovial joint, which subsequently restrict the function of the joint. Mechanical trauma or degenerative disorders are the major causes of articular cartilage injuries (Chubinskaya et al., 2015) . Traumatic cartilage lesions may increase the risk of developing osteoarthritis (OA) by more than four times (Muthuri et al., 2011) .
This fast-growing chronic disease is expected to be the fourth leading cause of disability by 2020 (Cross et al., 2014) . Commonly used surgical and nonsurgical OA treatment modalities include intraarticular injections of soluble materials, such as corticosteroids or hyaluronate, autologous blood products, nonsteroidal anti-inflammatory drugs (NSAIDs) and arthroscopic lavage. These procedures improve OA symptoms to a certain degree but do not heal completely the progressive loss of joint www.ecmjournal.org A Islam et al. Umbilical cord MSCs are potent immunomodulators functions (Lee and Wang, 2017; Wolfstadt et al., 2015) . Additionally, the treatment of localised cartilage injuries with cell-based therapies benefits patients with debilitative knee functions and delays the onset of secondary OA (Ogura et al., 2017) . Although autologous chondrocytes are used as an intuitive source for cell-based therapy (Knutsen et al., 2016; , in recent years, mesenchymal stromal cells (MSCs) are gaining attention as an alternative and potentially effective therapeutic tool for cartilage lesions. MSCs are successfully isolated and expanded in vitro from numerous tissues sources. MSCs represent a defined population of multipotent progenitor cells residing in the perivascular niche of nearly all human tissues, although different views exist (Crisan et al., 2008; Guimaraes-Camboa et al., 2017) . MSC differentiation capacity and immunomodulatory properties are demonstrated in vitro, irrespective of tissue sources (Ghannam et al., 2010) . However, in vitro studies show that MSCs from different origins differ in their lineage-specific differentiation capacity and their functional potential (Garcia et al., 2016; Islam et al., 2016; Subramanian et al., 2015) . In addition, a systematic review of intra-articular injection of bone marrow MSCs in humans has concluded that articular stem cell therapies are safe (Peeters et al., 2013) . Some preclinical studies in animals demonstrate the in vivo efficacy of MSCs from different sources, including autogenic, allogeneic and xenogeneic, in OA management. However, none of these studies has compared the optimal source of MSCs (Ozeki et al., 2016; Saulnier et al., 2015; Singh et al., 2014; Yang et al., 2015) . Therefore, the choice of optimal MSC source for a given clinical implication has yet to be elucidated.
In mechanistic terms, it is not well established how MSCs exert their effects in vivo. Liechty et al. (2000) propose that MSCs promote tissue regeneration by engraftment of cells in damaged areas and transdifferentiation into tissue-forming cells to promote repair. Recently, paracrine signalling and release of potent bioactive factors have emerged as modulators of the microenvironment during tissue healing (Gnecchi et al., 2016; Iso et al., 2007; Prockop, 2009 ). In the field of cartilage repair and OA, the fate of implanted cells during biological repair procedures and their contribution to rebuilding the damaged tissue is mostly unknown. Previous studies in animals suggest that most of the repaired tissue is composed of cells of unknown origin migrating to the lesion (Dell'Accio et al., 2003; Grande et al., 1989) . A recent human clinical trial has concluded that allogeneic bone marrow MSCs function as a source of stimulatory and trophic factors, which orchestrate tissue repair rather than differentiating into the host tissue (de Windt et al., 2017) .
Clinical procedures based on autologous MSC transplantation, including bone marrow or adipose tissue MSCs, may provide beneficial effects, but are associated with invasive harvesting procedures, twostage operations and long-time cell expansion ex vivo. Allogeneic MSCs harvested from umbilical cords, amniotic membrane and placenta might represent alternative sources for one-stage cell-based therapies. In addition to their pro-angiogenic properties, anti-inflammatory phenotype and multi-lineage differentiation potential, these allogeneic MSCs are well tolerated and elicit low immunogenic responses as their adult counterparts (Balasubramanian et al., 2012; Donders et al., 2015) . Differently from the investigation into the neo-tissue-forming ability, the role of secreted bioactive molecules in the context of paracrine signalling and immunomodulation have not been comprehensively explored between cells from adult joints and young cells. The aim of the present study was to find the most suitable cell source to promote immunomodulation and chondrogenesis from the paracrine signalling perspective. The number of published studies presenting comparative analyses of secretory profiles between different cell types is very limited (Amable et al., 2014; Dabrowski et al.., 2017) . Among those, the present study was the only one applying both large-scale secretomics and multiplex protein analyses and integrating functional immune assays to validate the results.
The present study compared the secretome of culture-expanded cells harvested from four different tissues sources comprising articular cartilage (ACs), Hoffa's fat pad stromal cells (HFPSCs), synovial membrane stromal cells (SMSCs) and umbilical cords stromal cells (UCSCs Table 1. A macroscopic observation was made by the operating surgeon to assess the inflammatory state of the sample. Patients with inflammatory joint diseases and very advanced OA were excluded; however, both secondary post-traumatic and primary OA patients were included in the study. Fat pad and synovial membrane tissues were harvested from TKR patients. UCSCs were isolated from seven umbilical cords immediately after birth. Buffy-coats for isolation of peripheral blood mononuclear cells (PBMCs) were collected from healthy donors from the local blood bank (REK Nord 2014/401). All patients provided written informed consent.
Isolation and culture of human stromal cells
Macroscopically-normal-looking cartilage, corresponding to cartilage areas looking intact to the eye and presenting no signs of abnormalities, such as tears, scratches, rugose or eroded tissue, was collected from femoral condyles during total knee replacements and was used to isolate human chondrocytes. All cell types were isolated using a mixed enzymatic-explant method, as previously described (Islam et al., 2016; Islam et al., 2017) . Briefly, all tissue specimens were washed three times with sterile Dulbecco's phosphate buffered saline (PBS; D8537, Sigma-Aldrich) and minced into small pieces for subsequent enzymatic digestion in collagenase XI solution (≥ 800 units/mg solid; C9407, Sigma-Aldrich) at a final concentration of 1.25 mg/mL at 37 °C on a shaker at 400 rpm. Cartilage tissue specimens were digested for 3-4 h, other adult tissue specimens were digested only for 1-1.5 h. UCSCs were isolated from 40 mm-long cord fragments (also known as mixed cords) previously sterilised by immersion in 90 % ethanol for 30 s and enzymatically digested for 1 h collagenase XI. Partially digested tissues were centrifuged for 10 min at 800 ×g and resuspended in high-glucose Dulbecco's modified Eagle medium (DMEM; D5796; Sigma-Aldrich) before plating in a T-75 culture flask (156499; ThermoFisher Scientific). The culture medium was supplemented with 62 mg/L L-ascorbic acid (103033E, BDH Laboratory, Pole, UK), 1 % penicillin and streptomycin (P/S; P4333, SigmaAldrich) and 20 % foetal bovine serum (FBS; S0115, Biochrom) to promote cell attachment. All cells were incubated in a humidified atmosphere containing 5 % CO 2 at 37 °C. After the initial 24 h, primary cultures were expanded in 10 % FBS-supplemented medium and the medium was changed every 3-4 d until the cultures became confluent. Cells from all tissue sources were used for experiments at passage (P) 3 and 4.
Preparation of conditioned medium (CM)
Serum-containing CM was used in the functional assays with PBMCs and macrophages, whereas serum-free CM was used for protein-arrays and secretomics. Upon reaching 70-80 % confluence, culture flasks were thoroughly washed with warm PBS and the medium was replaced with fresh highglucose DMEM containing 1 % P/S, with or without 10 % FBS. Serum-free medium was supplemented with 1 µg/mL dexamethasone (PZN-3103491; Galenpharma, Kiel, Germany) and 1 : 1000 insulintransferrin-selenium supplement (ITS; 354351; Corning). For priming of cells with pro-inflammatory cytokines, growth media were supplemented for 48 h with 50 ng/mL each of tumour necrosis factor alpha (TNF-α; 300-01A, PeproTech) and interferon gamma (IFNγ; 300-02, PeproTech). CM was collected after 48 h, centrifuged at 4500 ×g for 10 min, filtered through a 0.22 µm porous membrane (GSWP04700; Millipore) and used immediately for experiments or stored at -70 °C for further analysis. Cells were counted for each culture condition and the value used to normalise the measured expression of cytokines and growth factors in the CM. In functional assays with PBMCs and macrophages, the fresh culture medium was diluted with serum-containing CM for 20 min at 4500 ×g in PBS to a final volume of 500-800 µL using a 5 kDa molecular weight cut-off (MWCO) Vivaspin 6 column (Z614440-25EA, SigmaAldrich). Protein concentration was measured using DC Protein Assay Kit (5000116, Bio-Rad). Protein samples were prepared as described before (Islam et al., 2019) . Briefly, protein samples (100 µg/tube) were reduced in 5 mM dithiothreitol (D9779, SigmaAldrich) for 30 min at 70 °C. Samples were alkylated by incubation with 375 mM iodoacetamide (90034, ThermoFisher Scientific) at room temperature for 30 min in the dark. Protein samples were collected as dry pellets after overnight precipitation in prechilled acetone (270725, Sigma-Aldrich) at − 20 °C. Dry pellets containing 100 µg of protein were resuspended in 100 µL of 2 M urea (U1250, SigmaAldrich) with 50 mM triethylammonium bicarbonate (TEAB; 90114, ThermoFisher Scientific). Only 25 µg of protein per sample were taken for further analysis. Samples were pre-digested for 6 h with 1 : 100 (w/w) LysC endopeptidase (125-05061, Wako Chemicals, Neuss, Germany) with 1 mM final concentration of CaCl 2 , followed by further dilution with 50 mM TEAB in 1 M urea and digestion overnight in 1 : 20 (w/w) trypsin (V511A, Promega). 5 µL trifluoroacetic acid (10 %) (28904, ThermoFisher Scientific) were added to each tube and centrifuged at 16,000 ×g for 10 min. OMIX C18 tips were used for sample cleanup and concentration. Samples containing 0.2 % formic acid (FA; 28905, ThermoFisher Scientific) were loaded into a ThermoFisher Scientific EASYnLC1000 system and EASY-Spray column (C18, 2 µm, 10 nm, 50 µm, 500 mm). Peptides were fractionated using a 2-100 % acetonitrile (51101, ThermoFisher Scientific) gradient in 0.1 % FA at a flow rate of 250 nL/min over 180 min. The separated peptides were analysed using a ThermoFisher Scientific Q-Exactive mass spectrometer. Data were collected by Top10 method in data-dependent mode. The raw data were processed using MaxQuant (v 1.5.6.0) for label-free protein quantification (LFQ were generated to identify differentially expressed proteins using FDR < 0.01. Quantitative measurements (two replicates) were performed according to manufacturers' guidelines using Luminex Bio-Plex 200 system (Bio-Rad). In addition, quantification of PGE2 (KGE004B), IL-4 (DY204-05), IL-10 (DY217B-05) and the five growth factors TGF-β1 (DY240-05), BMP-2 (DY355-05), IGF-1 (DY291-05), PDGF-AB (DY222) and basic fibroblast growth factor (bFGF) (DY233-05) was performed by enzyme-linked immunosorbent assay (ELISA). All ELISA kits were purchased from R&D Systems and performed according to the manufacturer' instructions. Measured protein concentrations were normalised to cell number at specific culture conditions and expressed as pg/mL/10 6 cells.
Multiplex protein arrays

Isolation and culture of human PBMCs
PBMCs were isolated from buffy-coats (n = 5) of whole blood using Lymphoprep™ (1114545, Alere Technologies, Oslo, Norway) following the manufacturer' instructions. Briefly, peripheral blood was diluted in sterile PBS (1 : 1) and slowly layered over a Lymphoprep™ gradient in a 50 mL tube. The tube was centrifuged at 800 ×g for 30 min at room temperature. PBMCs were collected from the gradient-interface with a Pasteur pipette, followed by washing three times for 10 min at 400 ×g with phosphate NaCl (PBSA) containing PBS and 0.2 % bovine serum albumin (BSA; 130-091-376, Miltenyi Biotec). PBMCs were cultured in growth medium containing Rosewell Park Memorial Institute medium (RPMI-1640; R8758, Sigma-Aldrich), 1 % P/S and 10 % FBS in a humidified atmosphere (5 % CO 2 ) at 37 °C.
PBMC proliferation assay PBMC proliferation was assessed using the carboxyfluorescein succinimidyl ester (CFSE) dilution assay (10009853, Cayman). Cultured PBMCs were washed in pre-warmed sterile PBS and centrifuged at 400 ×g for 5 min before incubation with www.ecmjournal.org CFSE for 15 min at 1 : 400 dilution. CFSE-stained PBMCs were cultured in RPMI, 1 % P/S and 10 % FBS in a 24-well plate at a density of 10 6 cells/well. PBMCs were stimulated with 10 µg/mL mitogen phytohemagglutinin (PHA; 1249738, Roche) for 5 d to induce proliferation. Half of the medium was replaced with fresh medium after the second day. The proliferation assay was performed on a BD FACSAria III flow cytometer (BD Biosciences) and the data were analysed by FlowJo software (Tree Star Inc., Ashland, OR, USA). CM from stromal cells was added to the culture of PHA-activated PBMCs from day 1 at 1 : 1 ratio with fresh culture medium. CM from the last 3 d of PBMC proliferation was collected to measure cytokine profiles. CM derived from PBMCs was centrifuged at 4500 ×g for 5 min and filtered through a 0.22 µm porous membrane (GSWP04700; Millipore) before analysing TNF-α (DY210-05; R&D Systems) and IFN-γ (DY285-05; R&D Systems) content by ELISA.
PBMC migration assay PBMC migration assay was performed by Boyden chamber assay (Gorchs et al., 2015) . PBMCs were activated with 10 µg/mL PHA for 48 h before performing the assay. 100 ng/mL recombinant stromal cell-derived factor-1 (SDF-1; 300-28A, PeproTech) was used as a chemoattractant. 10 6 cells/100 µL PBMCs were added to the top chamber of Corning ® Costar ® Transwell ® cell culture inserts (6.5 mm diameter, 8 µm pores; CLS3464-48EA, Sigma-Aldrich). Bottom chambers contained either growth medium or serumrich CM from different stromal cells. After 2 h, PBMCs that migrated to the lower chamber were harvested and washed in PBSA by centrifugation at 400 ×g for 4 min followed by resuspension in 0.5 mL of PBSA. Lymphocytes population was gated using forward and side scatter and counted on a BD FACSAria III flow cytometer.
Isolation and culture of monocyte-derived macrophages
Monocytes were isolated from PBMCs using CD14 + magnetic-activated cell sorting (MACS; 130-050-201, Miltenyi Biotec) with minor modification from manufacturer' guidelines. Briefly, PBMCs were washed in MACS buffer containing autoMACS rinsing solution Miltenyi Biotec) and BSA (20 : 1) for 10 min at 4 °C. PBMCs were incubated with CD14 + microbeads at a concentration of 10 µL beads/10 7 cells in 40 µL of MACS buffer for 15 min at 4 °C. PBMCs were rinsed in MACS buffer and resuspended in an appropriate volume before passing through the MS column. CD14 + monocytes were eluted from the column and washed with ice-cold MACS buffer. The purity of eluted monocytes was checked by flow cytometry using anti-CD14-fl uorescein isothiocyanate (FITC)-conjugated antibody (130-098-063, Miltenyi Biotec) and its isotype control mouse . Fully transformed macrophages (M0-M) were achieved after 6 d incubation of CD14 + monocytes in a macrophage growing medium containing RPMI-1640, 1 % P/S, 10 % FBS and 100 ng/mL macrophage colony-stimulating factor (M-CSF; 300-25, PeproTech) in a humidified atmosphere (5 % CO 2 ) at 37 °C. The medium was replaced with fresh medium after 3 d.
Macrophage polarisation assay
For induction of the M1 phenotype (M1-M), M0-M were plated in a 6-well plate at a density of 2.5 × 10 6 cells/well and stimulated for 48 h with 100 ng/mL lipopolysaccharides (LPS; L6529-1MG, Sigma-Aldrich) and 20 ng/mL IFN-γ. To investigate the effects of cell secretomes on M1-M polarisation, macrophage culture medium was diluted with serum-rich CM (1 : 1) from different stromal cells. Macrophages were harvested after 48 h and washed in MACS buffer before analysing on BD FACSAria III flow cytometer. FlowJo software was used for analysing surface markers expression.
M1-M polarisation was characterised by surface marker expression of CD40 (130-099-385, Miltenyi Biotec), CD64 (130-100-415, Miltenyi Biotec), CD80 (130-110-371, Miltenyi Biotec), CD86 (560957; BD Biosciences) and HLA-DR (560943, BD Biosciences). All antibodies were phycoerythrin (PE)-conjugated and analysed with respective isotype controls, including mouse IgG1 (130-098-845, Miltenyi Biotec), Miltenyi Biotec) and mouse IgG2a (555574, BD Biosciences). For induction of M2 phenotype (M2-M), M0-M were stimulated with 4 µg/mL dexamethasone for 48 h and characterised by surface marker expression of 
Three-dimensional (3D) cultures
In vitro 3D chondrogenic assays of dedifferentiated chondrocytes was performed using a pellet culture method as described previously (Islam et al., 2016) . Briefly, chondrocytes were harvested at P3, centrifuged in a conical-bottom 96-well plate for 10 min at 1,100 ×g and incubated in culture medium for 48 h in low oxygen (3 % O 2 ) atmosphere. After 48 h, the newly formed neo-tissues were transferred to ultra-low attachment plate and cultured for 21 d in serum-free basal chondrogenic medium containing high-glucose DMEM, 62 mg/L L-ascorbic acid, 1 % P/S, 1 µg/mL dexamethasone, 1 : 1000 ITS in low oxygen (3 % O 2 ) atmosphere. Chondrogenesis was induced in the control samples by adding 10 ng/mL TGF-β1 (100-21C; PeproTech) and 100 ng/mL BMP-2 (120-02C; PeproTech) to the basal chondrogenic medium. To investigate the effect of stimulated and non-stimulated CM on chondrogenesis, the spheroids were incubated with CM in the absence of growth factors. Half of the CM was replaced with fresh CM twice a week. Spheroids were harvested after 21 d and fixed in 10 % formalin overnight for histological evaluation. Alcian blue solution (A5268, Sigma-Aldrich) was used for metachromatic staining of 4 µm-thick paraffin-embedded sections.
Statistical analysis
All statistical analyses were performed using IBM SPSS statistics version 24 (Chicago, IL, USA). Data were analysed using non-parametric KruskalWallis test, unless an exception was mentioned, and significance values were adjusted by Bonferroni correction for multiple comparisons. The level of significance was set at p < 0.05. Results are presented as density graphs, where each donor plotted as a dot in the dataset.
Results
Comparative protein profiles in supernatants of different stromal cells by LC-MS/MS proteomics
The MS secretomics data (identifier PXD011762) were deposited to the ProteomeXchange Consortium through the PRIDE partner repository (Vizcaíno et al., 2016) . All cell types were characterised by MSC surface markers and retained similar characteristics, as shown by Islam et al. (2016) . The cell secretome established in serum-free CM from each cell type (four unrelated donors per cell type) was analysed by LC-MS/MS proteomics. Only proteins identified in at least three donors in each group were considered for further analyses. Results showed more proteins identified in the supernatants of ACs (709) as compared to HFPSCs (641), SMSCs (567) and UCSCs (653) (Fig.  1a) . Comparative analysis of identified proteins revealed 472 proteins present in the supernatants of all four cell types. Only a minor fraction of proteins was exclusively found in supernatants of specific cell types, including 50 differentially expressed by UCSCs, 44 by ACs, 22 by HFPSCs and 2 by SMSCs. Hierarchical clustering of identified proteins revealed two major clusters, where one cluster comprised the four donors of UCSCs and the second cluster comprised all stromal cells from adult tissues (Fig.  1b) . Furthermore, among the stromal cells from adult tissues, the four AC donors were clearly separated from HFPSC and SMSC donors. Identified proteins were divided into six groups according to their functions using Gene Ontology Biological Process (GOBP) terms (Pazos and Chagoyen, 2009) (Fig.  2a) . Qualitative comparison of proteins in different pathways revealed no major differences between cell sources. Proteins involved in ECM remodelling were abundant in the supernatants of all cell types. In addition, all stromal cells released similar percentage of proteins involved in immunoregulation (~ 20 %) and secretion (~ 13 %) (Fig. 2a) .
Quantitative analyses of protein expression were performed using the LFQ approach (Patel et al., 2009) (Fig. 2b) . Six volcano plots representing all possible comparisons showed differentially expressed proteins by plotting log 10 of the fold change on the X-axis and − log 10 of the p-value on the Y-axis for each comparison (e.g. HFPSCs vs. ACs). Results revealed the largest differences in protein expression between www.ecmjournal.org UCSCs and all other adult stromal cells (FDR < 0.01). Proteins involved in cell signalling, such as TGF-β1, PDGFD and MCP-1, were significantly upregulated in UCSCs (FDR < 0.01), while catabolic proteins, such as MMPs, serpins and complement factors, were downregulated as compared to stromal cells from adult origin (Fig. 2b) . Notably, minor differences particularly in ECM remodelling proteins, such as MMPs and serpins, were observed while comparing stromal cells from cartilage and synovium (Fig. 2b) . Protein profiles belonging to specific pathways (ECM remodelling, cell communication and inflammation) were compared among the four cell types (Fig. 3) . Several MMPs, serpins, some complement factors and heat shock proteins were significantly downregulated in UCSCs (FDR < 0.01). On the other hand, cell signalling molecules including MCP-1, integrin (ITG)-β1, PDGFD, CSF-1, HLA-C and TGF-β1 were more abundant in the supernatants of UCSCs.
Determination of cytokines and growth factors in supernatants by multiplex protein arrays
A panel of 18 selected cytokines involved in inflammation and immunoregulation was measured in the supernatants of all stromal cells. Only IL-4, IL-6, IL-8, IL-12 and IL-17 were detected in supernatants of all cell types, whereas GM-CSF, IFN-α, IFN-γ, IL-1β, IL-1RA, IL-2, IL-2R, IL-5, IL-7, IL-13, IL-15 and TNF-α were not detected in any of the supernatants. From the panel of chemokines, MCP-1, MIP-1α and RANTES were detected in all supernatants, but eotaxin, IP-10, MIG and MIP-1β were not detected. Overall, the levels of IL-6, MCP-1 and PGE2 were increased in UCSCs supernatants as compared to other cell types, whereas the levels of IL-17, MIP-1α and RANTES were decreased (Fig. 4) . The concentration of IL-17 and MIP-1α was significantly lower in the UCSC supernatant as compared to AC supernatant and the levels of PGE2 was significantly higher in UCSC supernatants as compared to HFPSC supernatant (Fig. 4) . With regards to the expression of proteases, only MMP-13 was not detectable, whereas MMP-1, MMP-3, MMP-7 and MMP-9 were detected to some degree in all serum-free CM (Fig. 5) . The secretion of MMP-1, MMP-3, MMP-7 and MMP-9 was in general lower in UCSCs as compared to all other cell types. Significant differences were found for MMP-3 and MMP-7 when comparing UCSCs and ACs. The anabolic growth factors TGF-β1, BMP-2 and bFGF were detected at low levels in supernatants of the four cell sources, whereas IGF-1 and PDGF-AB could not be detected. Additionally, TGF-β1 was significantly elevated in UCSCs as compared to HFPSCs (Fig. 5) . To check for possible effects of serum supplementation on the production of cytokines by MSCs, the expression of TNF-α, IFN-γ, SMSCs. These plots show each protein with − log 10 (p-value) and log 10 of fold change of the comparison on the Y-axis and X-axis, respectively. Proteins with larger fold change and lower p-value are plotted further away from zero on each axis. Proteins that are significantly up-and down-regulated (p < 0.01) are represented in green and red, respectively. www.ecmjournal.org IL-6 and IL-12 in both serum-containing and serumfree CM from all four cell types was analysed. From the analysed cytokines, only the expression of IL-6 was considerably changed in the presence of serum (Fig. 6 ).
UCSC supernatants exerted stronger immunosuppressive effects on activated PBMCs
To investigate the immunomodulatory effects of cell supernatants on activated PBMCs, in vitro lymphocytes proliferation and migration assays were performed (Fig. 7a) . PHA-activated PBMCs were incubated for 5 d in the presence or absence of serumcontaining CM from the different cell sources. The proliferation assay revealed that UCSC supernatants blocked PBMC proliferation (p = 0.06) when compared with PHA-treated controls (Fig. 7a,b) . CM from ACs did not block PBMC proliferation, while HFPSCs (71 ± 5 %) and SMSCs (68 ± 3 %) had a minor effect. In the migration assay, both UCSCs and SMSCs blocked the migration of activated PBMCs as compared to positive controls (38 ± 2.5 % and 38 ± 1.2 % vs. 44.2 ± 0.5 %, respectively) (Fig. 7b) . To further investigate the immunomodulatory effects of MSC supernatants, the expression of TNF-α and IFN-γ in PBMCs-CM was measured. Values were normalised against residual expression levels present in supernatants of stromal cells. Supernatants from HFPSCs and SMSCs stimulated the production of TNF-α and IFN-γ above the levels achieved by PHA treatments. Importantly, supernatants from UCSCs suppressed the production of both TNF-α and IFN-γ by activated PBMCs, reaching significant differences when compared to HFPSCs (Fig. 7c) .
Immunomodulatory properties of supernatants after stimulation of MSCs with pro-inflammatory cytokines TGF-β1, PGE2, IL-4 and IL-10 were measured in the supernatants of stimulated and non-stimulated stromal cells by ELISA. Only TGF-β1 and PGE2 were detected in the supernatants of both stimulated and non-stimulated cells (Fig. 8a) , whereas IL-4 and IL-10 were not detected. In supernatants of cells stimulated with pro-inflammatory cytokines, the level of TGF-β1 was increased in AC cultures (p = 0.09) but unchanged in SMSC and UCSC cultures. The amount of secreted PGE2 significantly increased in the supernatants of stimulated ACs and SMSCs (Fig. 8a ). In addition, PBMC proliferation assay demonstrated superior blocking capacity of supernatants from primed adult stromal cells but not from UCSCs (Fig. 8b) .
UCSC supernatants exerted superior antiinflammatory effects on M1 activated macrophages
Macrophage polarisation assays were performed as previously reported (Ambarus et al., 2012; Vogel et al., 2014) . A panel of co-stimulatory molecules and 
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cytokines to characterise macrophage polarisation was chosen based on validation tests using different stimulants. Divergent expression of these markers was observed in the presence of different stimulants. In addition, IL-10 expression resulted to be an irrelevant marker for M2 polarised macrophages. In the validation test, increased IL-10 production was observed in the presence of LPS and IFN-γ (for M1 induction) as compared to dexamethasone or TGF-β1 and IL-4 stimulation (for M2 induction) (data not shown). These discrepancies are also reported by Chanteux et al. (2007) and Vogel et al. (2014) . Moreover, CD163 was a suitable marker for dexamethasonestimulated M2 polarised macrophages but not for TGF-β1 and IL-4 stimulation. The discrepancy concerning the expression of M2 markers is also demonstrated by Jaguin et al. (2013) . The immunomodulatory effects on M1 polarised macrophages were investigated by characterisation of surface marker expression (CD40, HLA-DR, CD64, CD80, CD86) and inflammatory cytokines release (Fig. 9) . Supernatants from all stromal cell types suppressed the surface expression of HLA-DR on activated macrophages, whereas only UCSC supernatants were able to significantly suppress the expression of CD40. On the other hand, supernatants from ACs were able to significantly increase the expression of the co-regulatory receptors CD80 and CD86 above the levels of M1 activation (Fig. 9b) . In contrast to ACs and UCSCs, supernatants from HFPSCs and SMSCs increased the surface expression of CD64 above M1 activation levels. None of the supernatants was able to alter the expression of the M2 phenotype marker CD163. With regards to cytokine profiles, CM from all cell types was able to reduce the production of TNF-α, IL-6 and IL-12 by M1-M. Of note, a significant reduction of IL-6 and IL-12 concentration was only achieved by UCSCs (Fig. 9c) .
Effects of UCSC CM on AC chondrogenesis
To check the chondrogenic potential of UCSC secretomes, the effects of UCSCs-CM on the expression of cartilage signature genes and the tissueforming capacity of dedifferentiated chondrocytes were investigated. Incubation with UCSCs-CM positively influenced gene expression of COL2A1, SOX9 and ACAN as compared to non-stimulated (Fig. 10) ; however, the differences were not significant except for ACAN. The CM of both stimulated and non-stimulated UCSCs significantly upregulated the expression of ACAN as compared to the control P3 chondrocytes (Fig. 10) . On the other hand, in the 3D culture assays, no differences were observed in cartilage neo-tissue formation by histology when comparing pellets incubated in the presence or absence of UCSCs-CM (Fig. 11) .
Discussion
The main objective of the study was to ascertain which source of stromal cells possesses the most favourable secretome to promote tissue repair. Given the importance of the MSC paracrine signalling, large-scale comparative analyses of cell secretomes were performed and functional studies with cell supernatants were conducted on immune cells to compare the constitutive immunomodulatory capabilities of different MSCs. Overall, the results demonstrated that stromal cells from umbilical cord matrix exhibited superior anti-inflammatory and trophic effects when compared with adult ACs, HFPSCs and SMSCs. All cell sources were expanded in monolayer cultures in the serum-supplemented media for some weeks, as done in standard cell transplantation procedures. To facilitate the analyses of secretory profiles by LC-MS/MS proteomics, the media were conditioned under serum-free conditions. Multiplex protein arrays were performed with the same serumfree CM that was used for proteomics, allowing direct comparisons of results. However, functional assays with immune cells were performed with serumsupplemented CM, as serum deprivation affects proliferation and induces apoptosis in lymphocytes and macrophages, respectively (Sato et al., 2009; Wei et al., 2006) . Short periods of serum deprivation do not affect the cell viability of mesenchymal cells (Boraldi et al., 2008) . However, some changes in the secretome could occur upon changes in serum supplementation. Significantly higher expression of IL-6 was only observed in the presence of serum in all four cell types (Fig. 6) . Although only minor phenotypic changes were expected in cells associated with serum presence, alterations in the expression of some bioactive molecules could occur and should be taken into consideration.
Currently, MSCs are viewed as "drugstores" with the potential to modulate the phenotype, migration and activation of resident tissue and inflammatory cells (Caplan and Correa, 2011) . This has led researchers to study MSC-mediated paracrine effects and profiles of secreted proteins from different mesenchymal stromal cell types. Previous studies comparing secretory profiles from different MSC sources highlight the existence of differentially expressed factors, with impact on angiogenesis, matrix remodelling, inflammation and immunosuppression (Amable et al., 2014; Dabrowski et al., 2017; Hsiao et al., 2012; Li et al., 2015) . The qualitative analyses using a large-scale proteomic approach revealed similar protein profiles, where most of the identified proteins were present in all cell supernatants. However, after hierarchical clustering of protein profiles from all donors, UCSC secretomes single out from the other adult cell sources (Fig. 1b) . Quantitative analyses of the secretome data revealed that proteins involved in cell signalling, such as TGF-β1 and PDGFD, were upregulated in UCSC supernatants, while catabolic proteins, such as MMPs, serpins and complement factors, were downregulated when compared to stromal cells from adult origin. TGF-β1 is a master driver of chondrogenesis and has pleiotropic effects in OA pathogenesis (Tang et al., 2015; Zhang et al., 2015; Zhen et al., 2013) . In addition, TGF-β1 has antiapoptotic effects (Rehman et al., 2004) . Observations from other studies are disparate and include cell sources that were not used in the present study; Fig. 6 . Cytokine expression by all cell sources in serum-free and serum-supplemented conditions. The secretion of selected cytokines and factors was assessed by ELISA. TNF-α, IFN-γ and IL-12 were not detected. Data were analysed using Mann-Whitney U comparison between serum-free and serumcontaining CM of each cell type. * p < 0.05; n = 4 donors/cell sources. www.ecmjournal.org Umbilical cord MSCs are potent immunomodulators however, the superior anabolic phenotype of UCSCs, including the highest expression of TGF-β1 among the compared cell types, is also observed by Dabrowski et al. (2017) . Data from the multiplex protein analyses revealed a significant reduction of MMPs and increased expression of TGF-β1 by UCSCs, thus reasserting observations made in the large-scale proteomic approach. Altogether, these observations highlighted the less catabolic phenotype of UCSCs when compared to the three other adult MSCs. The immunomodulatory profile of the different MSCs was also investigated by proteomics and multiplex arrays. Secretome analyses revealed comparable expression of complement components, heat-shock proteins, galectins and immunoregulators, such as CSF-1, MCP-1, MIF and TGF-β1, among the different cell sources. The data from multiplex protein arrays showed enhanced expression of the immunomodulators IL-6, MCP-1 and PGE2 and reduced expression of IL-17 and MIP-1α in UCSCs. Notably, stimulation of stromal cells with proinflammatory cytokines increased the expression of PGE2 in all cell types. However, a limitation of the study was the relatively low number of biological replicates, where the inclusion of more biological replicates could prove to be statistically significant for most of the analysed cytokines. IL-6 has an omnidirectional role in maintaining biological functions, whereas it has deleterious effects in the joint (Poree et al., 2008; Sui et al., 2009) . However, selective depletion of IL-6 in animals is associated with accelerated joint degeneration upon ageing (de Hooge et al., 2005) . Bouffi et al. (2010) demonstrate IL-6-dependent inhibition of local inflammation in experimental arthritis. MCP-1 (also called CCL2), MIP-1α (CCL3) and IL-17 are all potent inflammatory factors mediating recruitment and activation of myeloid cells. Their presence is associated with cartilage degeneration and progression of OA (Appleton et al., 2015; Snelling et al., 2017; Wang et al., 2017; Xu et al., 2015; . IL-17 inhibits chondrogenesis and promotes MMPs in chondrocytes (Benderdour et al., 2002; Kondo et al., 2013) . PGE2 regulates phenotype and functions of pro-inflammatory macrophages and natural killer (NK) cells (Manferdini et al., 2017) , however, the overall role of this factor in OA progression and cartilage homeostasis is still controversial Miwa et al., 2000; Otsuka et al., 2009) . Despite the difficulty to reach general conclusions due to the pleiotropic nature of many chemokines and cytokines, the observations based on the global expression of released factors indicated that UCSCs displayed a more immunosuppressive and anti-inflammatory phenotype than their adult counterparts.
To investigate further the paracrine potential of the different MSCs on immunomodulation, functional assays were conducted on lymphocytes and macrophages. Results using functional assays www.ecmjournal.org A Islam et al. Umbilical cord MSCs are potent immunomodulators harmonised with protein profiles, highlighting the superior immunosuppressive phenotype of UCSCs as compared to the other MSCs. The MSC ability to regulate inflammation and immunity has been the focus of intense research over recent years (Donders et al., 2018; von Bahr et al., 2012) . Many in vitro studies show that mesenchymal cells from multiple sources, including differentiated connective tissue cells, such as chondrocytes and fibroblasts, have the potential to regulate inflammation and T-cell functions to some extent (Bouffi et al., 2011; Lohan et al., 2016) . Still, there is no consensus on which cell source is the most powerful in this respect. Most published studies compare bone marrow, adipose tissue and foetal tissues with different outcomes. Some comparative studies demonstrate that bone marrow MSCs have slightly superior immunosuppressive capacity than other MSCs (Heo et al., 2016; Karaoz et al., 2017) . In line with the observations of the present study, some groups observe superior immunosuppressive abilities by MSCs from cords (Jin et al., 2013; Najar et al., 2012) . The chondro-inductive potential of UCSC supernatants on dedifferentiated chondrocytes was also tested in the present study. Whilst cartilage reference genes were upregulated after incubation with UCSCs-CM, no clear differences where observed in 3D neo-tissue formation in vitro. These results put forward the anabolic potential of the UCSC secretome; however, the concentration of anabolic factors, such as TGF-β1, in supernatants remained insufficient to trigger proper chondrogenesis from dedifferentiated chondrocytes. Priming of MSCs is extensively documented and is recommended as a mandatory step to unleash the full immunosuppressive potential of MSCs (GomezAristizabal et al., 2017; Najar et al., 2012; van Buul et al., 2012) . In the present study, stimulation of adult stromal cells with pro-inflammatory cytokines altered the expression of some immunoregulatory factors and increased the blocking effects over PBMCs by adult MSCs (Fig. 8) . On the other hand, the effects exerted by primed UCSCs on PBMC proliferation were unchanged. These differences could be due to early embryonic differentiation of the cell phenotypes. Notably, constitutive immunoregulation by nonstimulated UCSCs is observed in an OA rabbit model (Saulnier et al., 2015) . In this context, ex vivo priming of MSCs is related to few controversial outcomes in vivo, describing increased immunogenicity of prestimulated MSCs (Papadopoulou et al., 2012; Treacy et al., 2014) .
In clinical settings, MSCs from different sources are investigated for the treatment of focal cartilage lesions and OA (Lee and Wang, 2017). Articular Fig. 10 . Effects of UCSCs-CM on cartilage signature gene expression of dedifferentiated chondrocytes in monolayer cultures. Relative expression of COL2A1, COL1A1, SOX9 and ACAN by chondrocytes in the presence of CM from stimulated and non-stimulated ACs and UCSCs. Dedifferentiated chondrocytes at P2 and P3 in the absence of CM were used as controls. p ˂ 0.05; n = 3 donors. www.ecmjournal.org chondrocytes, bone marrow and adipose tissue stromal cells are the most commonly used sources for cartilage repair (Vonk et al., 2015) . These studies mostly assess safety and efficacy of used MSCs for specific clinical implications. A comparative study in humans argues that autologous SMSCs exert superior healing outcomes (Akgun et al., 2015) . On the other hand, in preclinical models, MSCs from cords exert immunosuppression and disease regression in experimental models of OA and autoimmune disorders (Donders et al., 2015; Saulnier et al., 2015; Yang et al., 2015) . In contrast to MSCs from autologous sources, there are only few ongoing trials exploring the potential of allogeneic UCSCs for both OA management and focal cartilage repair in humans (NCT02580695, NCT02291926, NCT03166865 and NCT03358654), without published outcomes hitherto. Confirming the results of the present comparative study in suitable animal models would provide more insight into the use of UCSCs for cartilage disorders in the clinics.
Conclusions
Traditionally, the regenerative potential of MSCs has been directly linked to their multipotent differentiation and tissue-forming capabilities. Nowadays, increasing attention is given to their role as paracrine modulators. In the field of articular cartilage lesions and degenerative joint diseases, there is no consensus on the best cell source for treatment. Considering the relevance of paracrine signalling, the present study compared the secretome among MSCs from different sources. Both the molecular analyses and the functional assays indicated that UCSCs displayed superior anti-inflammatory and trophic effects when compared to MSCs from adult tissues. The hypoimmunogenic nature of UCSCs, along with their high abundance, simple isolation and favourable protein profiles make this cell source an attractive tool for off-the-shelf allogeneic adjuvant therapy.
